Bio Key International (BKYI) risk factors, FY2025 10-K

Bio Key International's FY2025 10-K, filed Jun 12, 2026, lists 33 risk factors in 3 groups. Against the prior year's 34: 1 new, 2 dropped, 5 substantially reworded.

Risk factors listed
333 groups
New this year
1vs 34 last year
Dropped
2since the prior 10-K
Substantially reworded
5of those kept
Section length
8k wordsItem 1A

What the changes say

  • Nasdaq trading was suspended May 13, 2026, and the stock now trades on OTC Markets, increasing liquidity and capital-access concerns.
  • A new control-risk disclosure cites possible material weaknesses, limited cash, losses, negative operating cash flow and substantial doubt about continuing as a going concern.
  • Warrants and options reserved for issuance fell to 794,073 shares after a 1-for-10 reverse split, but could still substantially dilute shareholders.
  • The geopolitical risk now covers the Russia-Ukraine and US-Iran wars, while tariff language is less specific about affected countries.

What changed since the prior 10-K

New

  • NewBUSINESS AND FINANCIAL RISKS

    Material weaknesses could materially and adversely affect our operations, financial condition, reputation and stock price

    Internal-control failures could cause undetected misstatements, delayed reporting, reputational damage, and worsen financing and going-concern difficulties.

Dropped

  • DroppedBUSINESS AND FINANCIAL RISKS

    Legal, regulatory or market measures to address climate change may materially and adversely affect our future results of operations and financial condition

  • DroppedRISKS RELATED TO OUR COMMON STOCK

    If we fail to comply with the continued listing requirements of The Nasdaq Stock Market, our Common Stock may be delisted and the price of our Common Stock and our ability to access the capital markets could be negatively impacted

Reworded

  • 95% rewrittenBUSINESS AND FINANCIAL RISKS

    The impact of the Russian invasion of Ukraine, and the US-Iran war, and the international community ’ s response have created substantial political and economic disruption, uncertainty, and risk

    The risk now includes the US-Iran war, says no material harm has occurred yet, and focuses on impacts to the company, suppliers, customers and global economy.

    Was: The war in Ukraine and the international community’s response have created substantial political and economic disruption, uncertainty, and risk

  • 83% rewrittenRISKS RELATED TO OUR COMMON STOCK

    An active trading market for our common stock may not be sustained

    Nasdaq trading was suspended May 13, 2026; the stock now trades OTC Markets, where an active market may not develop or continue.

  • 41% rewrittenRISKS RELATED TO OUR COMMON STOCK

    We have issued a substantial number of warrants exercisable into shares of our common stock which could result in substantial dilution to the ownership interests of our existing stockholders

    Shares reserved for options and warrants decreased from approximately 4,275,056 to 794,073 after a 1-for-10 reverse split.

  • 31% rewrittenBUSINESS AND FINANCIAL RISKS

    Our failure to timely file our annual report on Form 10-K for the year ended December 31, 2025 has made us ineligible to use a Form S-3 to register the offer and sale of securities, which could adversely affect our ability to raise future capital

    The late filing now concerns the 2025 Form 10-K rather than 2023 filings and adds an assumption that Nasdaq listing continues.

    Was: Our failure to timely our annual report on Form 10-K for the year ended December 31, 2023 and our quarterly report on Form 10-Q for the period ended March 31, 2024 has made us ineligible to use a Form S-3 to register the offer and sale of securities, which could adversely affect our ability to raise future capital

  • 28% rewrittenBUSINESS AND FINANCIAL RISKS

    Our business could be adversely affected by trade tariffs or other trade barriers

    The disclosure no longer specifically names tariffs involving Mexico, Canada and Europe, but retains risks from US and retaliatory trade barriers.

All 33 risk factors

Headings as the filing states them, in filing order.

BUSINESS AND FINANCIAL RISKS

  1. 01Material weaknesses could materially and adversely affect our operations, financial condition, reputation and stock priceNew
  2. 02Historically, we have not generated significant revenue and have sustained substantial operating losses
  3. 03We may need to obtain additional financing to execute our business plan, which may not be available. If we are unable to raise additional capital or generate significant revenue, we may not be able to continue operations
  4. 04Our failure to timely file our annual report on Form 10-K for the year ended December 31, 2025 has made us ineligible to use a Form S-3 to register the offer and sale of securities, which could adversely affect our ability to raise future capital31% rewritten
  5. 05Our biometric technology has yet to gain widespread market acceptance and we do not know how large of a market will develop for our technology
  6. 06competition from non-biometric technologies that provide more affordable, but less robust, authentication (such as tokens and smart cards)
  7. 07Biometric technology is a relatively new approach to Internet security, which must be accepted in order for our WEB-key solution to generate significant revenue
  8. 08The market for our solutions is still developing and if the biometrics industry adopts standards or a platform different from our standards or platform, our competitive position would be negatively affected
  9. 09Our software products may contain defects which will make it more difficult for us to establish and maintain customers
  10. 10In order to generate revenue from our biometric products, we are dependent upon independent original equipment manufacturers, system integrators and application developers, which we do not control. As a result, it may be more difficult to generate sales
  11. 11companies which distribute goods, services or software applications over the Internet
  12. 12We face intense competition and may not have the financial and human resources necessary to keep up with rapid technological changes, which may result in our technology becoming obsolete
  13. 13Although we have made significant sales of our products throughout Asia and Africa in prior years, we have not been able to consistently enforce our contract rights and collect all receivables which has resulted in material write-offs
  14. 14We depend on key employees and members of our management team, including our Chairman of the Board and Chief Executive Officer, Chief Financial Officer, and our Chief Legal Officer, in order to achieve our goals. We cannot assure you that we will be able to retain or attract such persons
  15. 15We cannot assure you that the intellectual property protection for our core technology provides a sustainable competitive advantage or barrier to entry against our competitors
  16. 16We may be subject to claims with respect to the infringement of intellectual property rights of others, which could result in substantial costs and diversion of our financial and management resources
  17. 17If we are unable to effectively protect our intellectual property rights on a worldwide basis, we may not be successful in the international expansion of our business
  18. 18We may not achieve profitability if we are unable to maintain, improve our offerings
  19. 19We are subject to risks and uncertainties associated with the continued growth of our international operations, which may harm our business
  20. 20Our business could be negatively impacted by security threats, including cybersecurity threats, ransomware, and other disruptions
  21. 21Our failure to comply with applicable privacy, data protection and information security laws or related contractual obligations could subject us to significant liability and negatively impact our financial position and results of operation
  22. 22Our business could be adversely affected by trade tariffs or other trade barriers28% rewritten
  23. 23Scrutiny and evolving expectations from customers, regulators, investors, and other stakeholders with respect to our environmental, social and governance practices may impose additional costs on us or expose us to new or additional risks
  24. 24The impact of the Russian invasion of Ukraine, and the US-Iran war, and the international community ’ s response have created substantial political and economic disruption, uncertainty, and risk95% rewritten
  25. 25There is a scarcity of and competition for acquisition opportunities

Risks related to acquisition financing

  1. 26We may experience difficulties in integrating the operations, personnel and assets of any business we acquire which may disrupt our business, dilute stockholder value, and adversely affect our operating results
  2. 27To the extent we make any material acquisitions, our earnings may be adversely affected by non-cash charges relating to the amortization of intangible assets

RISKS RELATED TO OUR COMMON STOCK

  1. 28We have issued a substantial number of warrants exercisable into shares of our common stock which could result in substantial dilution to the ownership interests of our existing stockholders41% rewritten
  2. 29An active trading market for our common stock may not be sustained83% rewritten
  3. 30We may need to raise additional funds in the future through issuances of securities and such additional funding may be dilutive to stockholders or impose operational restrictions
  4. 31Because we do not expect to pay dividends for the foreseeable future, investors seeking cash dividends should not purchase our shares of common stock
  5. 32Provisions of our certificate of incorporation, bylaws and Delaware law may make a contested takeover of our Company more difficult
  6. 33The trading price of our common stock may be volatile

Other Bio Key International 10-Ks

  • FY2024 10-K risk factors
    34 risks

    The company faces severe liquidity challenges, requiring $812,000 monthly to operate while failing to generate sufficient revenue or timely file SEC reports.

    Filed Apr 23, 2025

About this page

The headings are the filing's own. The one-line readings and the overview are automated and can be wrong: read Item 1A of the 10-K for the exact wording.